Torgrim Tandstad

3.7k total citations · 1 hit paper
65 papers, 1.5k citations indexed

About

Torgrim Tandstad is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Torgrim Tandstad has authored 65 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Surgery, 26 papers in Pulmonary and Respiratory Medicine and 20 papers in Molecular Biology. Recurrent topics in Torgrim Tandstad's work include Testicular diseases and treatments (51 papers), Sexual Differentiation and Disorders (20 papers) and Sarcoma Diagnosis and Treatment (16 papers). Torgrim Tandstad is often cited by papers focused on Testicular diseases and treatments (51 papers), Sexual Differentiation and Disorders (20 papers) and Sarcoma Diagnosis and Treatment (16 papers). Torgrim Tandstad collaborates with scholars based in Norway, Sweden and United States. Torgrim Tandstad's co-authors include Gabriella Cohn‐Cedermark, Olbjørn Klepp, Eva Cavallin‐Ståhl, Roy M. Bremnes, Ulrika Stierner, Arne Solberg, Hege Sagstuen Haugnes, Carl W. Langberg, Olav Dahl and Anna Laurell and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Urology.

In The Last Decade

Torgrim Tandstad

62 papers receiving 1.4k citations

Hit Papers

European Association of Urology Guidelines on Testicular ... 2023 2026 2024 2025 2023 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. European Association of Urology Guidelines on Testicular Cancer: 2023 Update
    2023 99 citations Jan Oldenburg, Torgrim Tandstad et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Torgrim Tandstad Norway 17 1.3k 468 443 437 394 65 1.5k
Pat Cook United Kingdom 14 1.7k 1.4× 342 0.7× 424 1.0× 1.1k 2.6× 471 1.2× 23 2.3k
N. Vogelzang United States 15 707 0.6× 128 0.3× 391 0.9× 519 1.2× 214 0.5× 47 1.2k
M.A. Kuczyk Germany 22 696 0.5× 100 0.2× 530 1.2× 488 1.1× 161 0.4× 120 1.5k
R.J. Cohen United States 9 539 0.4× 171 0.4× 123 0.3× 306 0.7× 151 0.4× 28 984
K.‐P. Dieckmann Germany 17 766 0.6× 236 0.5× 414 0.9× 210 0.5× 348 0.9× 56 939
John W. Cullen United States 18 773 0.6× 118 0.3× 166 0.4× 326 0.7× 286 0.7× 29 1.1k
D Ondruš Slovakia 13 530 0.4× 148 0.3× 199 0.4× 257 0.6× 158 0.4× 98 791
A. Rey France 24 602 0.5× 162 0.3× 338 0.8× 649 1.5× 719 1.8× 55 1.7k
S. Ous Norway 18 676 0.5× 168 0.4× 134 0.3× 191 0.4× 243 0.6× 37 816
Ebbe Lindegaard Madsen Denmark 17 553 0.4× 170 0.4× 158 0.4× 326 0.7× 101 0.3× 36 940

Countries citing papers authored by Torgrim Tandstad

Since Specialization
Citations

This map shows the geographic impact of Torgrim Tandstad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torgrim Tandstad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torgrim Tandstad more than expected).

Fields of papers citing papers by Torgrim Tandstad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Torgrim Tandstad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torgrim Tandstad. The network helps show where Torgrim Tandstad may publish in the future.

Co-authorship network of co-authors of Torgrim Tandstad

This figure shows the co-authorship network connecting the top 25 collaborators of Torgrim Tandstad. A scholar is included among the top collaborators of Torgrim Tandstad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Torgrim Tandstad. Torgrim Tandstad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fosså, Sophie D., Torgrim Tandstad, Marianne Brydøy, et al.. (2025). Biochemical Hypogonadism in Aging Testicular Cancer Survivors: A Clinical Challenge. European Urology Open Science. 72. 10–16. 1 indexed citations
2.
Tandstad, Torgrim, Trond Velde Bogsrud, Eivor Hernes, et al.. (2024). Added Value of [18F]PSMA‐1007 PET/CT and PET/MRI in Patients With Biochemically Recurrent Prostate Cancer: Impact on Detection Rates and Clinical Management. Journal of Magnetic Resonance Imaging. 61(1). 466–477. 2 indexed citations
3.
Gerdtsson, Axel, Helene F. S. Negaard, Ingrid Glimelius, et al.. (2024). Initial surveillance in men with marker negative clinical stage IIA non‐seminomatous germ cell tumours. British Journal of Urology. 133(6). 717–724. 1 indexed citations
4.
Haugnes, Hege Sagstuen, Torgrim Tandstad, Olof Akre, et al.. (2024). miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR Study. The Journal of Urology. 212(5). 720–730. 4 indexed citations
5.
Gerdtsson, Axel, Gustav Torisson, Ulf Håkansson, et al.. (2023). Validation of a prediction model for post‐chemotherapy fibrosis in nonseminoma patients. British Journal of Urology. 132(3). 329–336. 2 indexed citations
6.
Tandstad, Torgrim, et al.. (2023). Pulmonary Function and Lung Fibrosis up to 12 Years After Breast Cancer Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 118(4). 1066–1077. 3 indexed citations
7.
Haugnes, Hege Sagstuen, et al.. (2021). Thromboembolic Events During Treatment with Cisplatin-based Chemotherapy in Metastatic Testicular Germ-cell Cancer 2000–2014: A Population-based Cohort Study. European Urology Open Science. 32. 19–27. 15 indexed citations
8.
Beyer, J., Laurence Collette, Gedske Daugaard, et al.. (2020). Prognostic factors in advanced seminoma: An analysis from the IGCCCG Update Consortium.. Journal of Clinical Oncology. 38(6_suppl). 386–386. 9 indexed citations
9.
10.
Glimelius, Ingrid, Gabriella Cohn‐Cedermark, Olof Ståhl, et al.. (2019). Cancer therapy and risk of congenital malformations in children fathered by men treated for testicular germ-cell cancer: A nationwide register study. PLoS Medicine. 16(6). e1002816–e1002816. 11 indexed citations
11.
12.
Bremnes, Roy M., Per Ole M. Gundersen, Mette Sprauten, et al.. (2016). Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors. Urologic Oncology Seminars and Original Investigations. 34(11). 487.e13–487.e20. 16 indexed citations
13.
Sprauten, Mette, Hege Sagstuen Haugnes, Marianne Brydøy, et al.. (2015). Chronic fatigue in 812 testicular cancer survivors during long-term follow-up: increasing prevalence and risk factors. Annals of Oncology. 26(10). 2133–2140. 47 indexed citations
14.
Tandstad, Torgrim, Olof Ståhl, Ulf Håkansson, et al.. (2015). The SWENOTECA group: A good example of continuous binational and multidisciplinary collaboration for patients with testicular cancer in Sweden and Norway. Scandinavian Journal of Urology. 50(1). 9–13. 15 indexed citations
15.
Oldenburg, Jan, Jorge Aparicio, J. Beyer, et al.. (2014). Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer. Annals of Oncology. 26(5). 833–838. 45 indexed citations
16.
Tandstad, Torgrim, Arne Solberg, Ulf Håkansson, et al.. (2014). Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols. Acta Oncologica. 54(4). 493–499. 7 indexed citations
17.
Tandstad, Torgrim, O. Ståhl, Ulf Håkansson, et al.. (2014). One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group. Annals of Oncology. 25(11). 2167–2172. 80 indexed citations
18.
Tandstad, Torgrim, Rune Smaaland, Arne Solberg, et al.. (2011). Management of Seminomatous Testicular Cancer: A Binational Prospective Population-Based Study From the Swedish Norwegian Testicular Cancer Study Group. Journal of Clinical Oncology. 29(6). 719–725. 141 indexed citations
19.
Tandstad, Torgrim, Gabriella Cohn‐Cedermark, O. Dahl, et al.. (2010). Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study. Annals of Oncology. 21(9). 1858–1863. 34 indexed citations
20.
Tandstad, Torgrim & Olbjørn Klepp. (2003). Neuron-specific Enolase in Testicular Cancer. Acta Oncologica. 42(3). 202–206. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pat Cook Breakdown of academic impact, for papers by N. Vogelzang Breakdown of academic impact, for papers by M.A. Kuczyk Breakdown of academic impact, for papers by R.J. Cohen Breakdown of academic impact, for papers by K.‐P. Dieckmann Breakdown of academic impact, for papers by John W. Cullen Breakdown of academic impact, for papers by D Ondruš Breakdown of academic impact, for papers by A. Rey Breakdown of academic impact, for papers by S. Ous Breakdown of academic impact, for papers by Ebbe Lindegaard Madsen
Rankless by CCL
2026